Sign in to view content

Treatment Response to Antioxidant Supplementation Based on CFH and ARMS2Â Genetic Risk Allele Number in AREDS Patients With No AMD at Baseline

Carl C. Awh, MD, FASRS

Video
Published 2016

Related

ASRS Presidents' Retina Young Investigators Award, Solving AMD: Moving Forward by Stepping Back
Jayakrishna Ambati, MD
Annual Meeting Talks
2016
Response to Ranibizumab of Eyes With Pigment Epithelial Detachments, Including Eyes That Developed RPE Tears: Data From the HARBOR Study
David A. Eichenbaum, MD, FASRS
Annual Meeting Talks
2016
HIPPA and Malpractice Pitfalls in Providing Care to Infants at Risk for Retinopathy of Prematurity (ROP) For Physicians Employing Digital Imaging Technologies
Antonio Capone, MD
Annual Meeting Talks
2016

Category: AMD-Non-Neovascular

See more